Menu
GeneBe

rs1957106

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_020529.3(NFKBIA):c.81C>T(p.Asp27=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.288 in 1,591,188 control chromosomes in the GnomAD database, including 68,258 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5326 hom., cov: 32)
Exomes 𝑓: 0.29 ( 62932 hom. )

Consequence

NFKBIA
NM_020529.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: 0.0270
Variant links:
Genes affected
NFKBIA (HGNC:7797): (NFKB inhibitor alpha) This gene encodes a member of the NF-kappa-B inhibitor family, which contain multiple ankrin repeat domains. The encoded protein interacts with REL dimers to inhibit NF-kappa-B/REL complexes which are involved in inflammatory responses. The encoded protein moves between the cytoplasm and the nucleus via a nuclear localization signal and CRM1-mediated nuclear export. Mutations in this gene have been found in ectodermal dysplasia anhidrotic with T-cell immunodeficiency autosomal dominant disease. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 14-35404564-G-A is Benign according to our data. Variant chr14-35404564-G-A is described in ClinVar as [Benign]. Clinvar id is 313117.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-35404564-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.027 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.324 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NFKBIANM_020529.3 linkuse as main transcriptc.81C>T p.Asp27= synonymous_variant 1/6 ENST00000216797.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NFKBIAENST00000216797.10 linkuse as main transcriptc.81C>T p.Asp27= synonymous_variant 1/61 NM_020529.3 P1

Frequencies

GnomAD3 genomes
AF:
0.251
AC:
38116
AN:
151672
Hom.:
5315
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.144
Gnomad AMI
AF:
0.225
Gnomad AMR
AF:
0.191
Gnomad ASJ
AF:
0.206
Gnomad EAS
AF:
0.260
Gnomad SAS
AF:
0.338
Gnomad FIN
AF:
0.387
Gnomad MID
AF:
0.213
Gnomad NFE
AF:
0.305
Gnomad OTH
AF:
0.236
GnomAD3 exomes
AF:
0.284
AC:
61676
AN:
217444
Hom.:
9164
AF XY:
0.292
AC XY:
35000
AN XY:
120014
show subpopulations
Gnomad AFR exome
AF:
0.140
Gnomad AMR exome
AF:
0.181
Gnomad ASJ exome
AF:
0.218
Gnomad EAS exome
AF:
0.265
Gnomad SAS exome
AF:
0.324
Gnomad FIN exome
AF:
0.411
Gnomad NFE exome
AF:
0.306
Gnomad OTH exome
AF:
0.277
GnomAD4 exome
AF:
0.292
AC:
419627
AN:
1439408
Hom.:
62932
Cov.:
39
AF XY:
0.293
AC XY:
209963
AN XY:
715466
show subpopulations
Gnomad4 AFR exome
AF:
0.136
Gnomad4 AMR exome
AF:
0.182
Gnomad4 ASJ exome
AF:
0.211
Gnomad4 EAS exome
AF:
0.263
Gnomad4 SAS exome
AF:
0.319
Gnomad4 FIN exome
AF:
0.407
Gnomad4 NFE exome
AF:
0.297
Gnomad4 OTH exome
AF:
0.276
GnomAD4 genome
AF:
0.251
AC:
38147
AN:
151780
Hom.:
5326
Cov.:
32
AF XY:
0.255
AC XY:
18942
AN XY:
74204
show subpopulations
Gnomad4 AFR
AF:
0.145
Gnomad4 AMR
AF:
0.192
Gnomad4 ASJ
AF:
0.206
Gnomad4 EAS
AF:
0.260
Gnomad4 SAS
AF:
0.338
Gnomad4 FIN
AF:
0.387
Gnomad4 NFE
AF:
0.305
Gnomad4 OTH
AF:
0.244
Alfa
AF:
0.280
Hom.:
7833
Bravo
AF:
0.229
Asia WGS
AF:
0.295
AC:
1001
AN:
3406

ClinVar

Significance: Benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ectodermal dysplasia and immunodeficiency 2 Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanNov 12, 2023This variant is classified as Benign based on local population frequency. This variant was detected in 32% of patients studied by a panel of primary immunodeficiencies. Number of patients: 31. Only high quality variants are reported. -
not provided Other:1
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
Cadd
Benign
9.4
Dann
Benign
0.95
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.6

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1957106; hg19: chr14-35873770; COSMIC: COSV53751429; COSMIC: COSV53751429; API